1. Home
  2. SBFM vs VANI Comparison

SBFM vs VANI Comparison

Compare SBFM & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$0.93

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.23

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
VANI
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
119.0M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
SBFM
VANI
Price
$0.93
$1.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$3.50
AVG Volume (30 Days)
386.7K
217.3K
Earning Date
04-03-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,305,891.00
$4,000,000.00
Revenue This Year
$40.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.11
N/A
52 Week Low
$0.25
$0.92
52 Week High
$3.05
$1.92

Technical Indicators

Market Signals
Indicator
SBFM
VANI
Relative Strength Index (RSI) 34.51 41.31
Support Level $0.27 $1.13
Resistance Level $1.24 $1.25
Average True Range (ATR) 0.07 0.07
MACD -0.01 -0.02
Stochastic Oscillator 27.64 17.39

Price Performance

Historical Comparison
SBFM
VANI

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: